Tse H, Li J, Zhao X, Chen F, Ho P, Shaw M
Curr Trends Immunol. 2014; 13:1-12.
PMID: 24795508
PMC: 4005425.
Shaw M, Zhao X, Tse H
J Vis Exp. 2012; (62):e3778.
PMID: 22507967
PMC: 3367719.
DOI: 10.3791/3778.
Li J, Zhao X, Skoff R, Shaw M, Tse H
J Neuroimmunol. 2011; 234(1-2):109-14.
PMID: 21482438
PMC: 3092848.
DOI: 10.1016/j.jneuroim.2011.03.008.
Merrill J
Neuropsychopharmacology. 2008; 34(1):55-73.
PMID: 18800062
PMC: 7100020.
DOI: 10.1038/npp.2008.145.
Peterson L, Tsunoda I, Libbey J, Fujinami R
Exp Mol Pathol. 2008; 85(1):28-39.
PMID: 18486939
PMC: 2614211.
DOI: 10.1016/j.yexmp.2008.03.005.
Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.
Polanczyk M, Yellayi S, Zamora A, Subramanian S, Tovey M, Vandenbark A
Am J Pathol. 2004; 164(6):1915-24.
PMID: 15161628
PMC: 1615766.
DOI: 10.1016/S0002-9440(10)63752-2.
Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.
Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M
J Neurosci. 2001; 21(13):4564-71.
PMID: 11425884
PMC: 6762348.
New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis.
Arnon R, Sela M, Teitelbaum D
J Neurol. 1996; 243(4 Suppl 1):S8-13.
PMID: 8965119
DOI: 10.1007/BF00873696.
A review of the clinical efficacy profile of copolymer 1: new U.S. phase III trial data.
Johnson K
J Neurol. 1996; 243(4 Suppl 1):S3-7.
PMID: 8965118
DOI: 10.1007/BF00873695.
Nitric oxide production in SJL mice bearing the RcsX lymphoma: a model for in vivo toxicological evaluation of NO.
Gal A, Tamir S, Tannenbaum S, Wogan G
Proc Natl Acad Sci U S A. 1996; 93(21):11499-503.
PMID: 8876164
PMC: 38086.
DOI: 10.1073/pnas.93.21.11499.
IL-12 unmasks latent autoimmune disease in resistant mice.
Segal B, Shevach E
J Exp Med. 1996; 184(2):771-5.
PMID: 8786337
PMC: 2192714.
DOI: 10.1084/jem.184.2.771.
Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier.
Osanai T, Nagai Y
Neurochem Res. 1984; 9(10):1407-16.
PMID: 6514110
DOI: 10.1007/BF00964667.
T lymphocyte lines in the study of autoimmune disease.
Wekerle H, Fierz W
Blut. 1984; 49(3):187-94.
PMID: 6206905
DOI: 10.1007/BF00319821.
Partial cross-reactivity by suppressor cells induced during different experimental autoimmune diseases.
Playfair J, de Souza J, Hutchings P, Cooke A
Clin Exp Immunol. 1985; 59(1):117-22.
PMID: 3156012
PMC: 1577156.
Immunological and immunopathological aspects of opsin-induced uveoretinitis.
Broekhuyse R, Kuhlmann E, Van Vugt A, Winkens H
Graefes Arch Clin Exp Ophthalmol. 1987; 225(1):45-9.
PMID: 2952558
DOI: 10.1007/BF02155803.
Functional characteristics of the developing brain after early postnatal neuroimmunization in rats: behavioral analysis.
ZUBOVA O, Oknina N
Neurosci Behav Physiol. 1989; 19(1):19-25.
PMID: 2747880
DOI: 10.1007/BF01148406.
Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.
DeFreitas E, Dietzschold B, KOPROWSKI H
Proc Natl Acad Sci U S A. 1985; 82(10):3425-9.
PMID: 2582411
PMC: 397788.
DOI: 10.1073/pnas.82.10.3425.
Experimental allergic orchitis in mice. V. Resistance to actively induced disease in BALB/cJ substrain mice is mediated by CD4+ T cells.
Teuscher C, Hickey W, Korngold R
Immunogenetics. 1990; 32(1):34-40.
PMID: 1973683
DOI: 10.1007/BF01787326.
Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype.
Soloway P, Fish S, Passmore H, Gefter M, Coffee R, Manser T
J Exp Med. 1991; 174(4):847-58.
PMID: 1919438
PMC: 2118967.
DOI: 10.1084/jem.174.4.847.
